Global Rare Disease Clinical Trials Market Report 2023: Sector is Expected to Reach $24.25 Billion by 2030 at a CAGR of 9.7% - ResearchAndMarkets.com

Government initiatives that encourage product development, such as the Orphan Drug Act, are further expected to assist industry growth.